Design and characterization of a novel tumor-homing cell-penetrating peptide for drug delivery in TGFBR3 high-expressing tumors.

Wu, Yi-Jie et al.·Chemical biology & drug design·2023·
RPEP-075622023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Design and characterization of a novel tumor-homing cell-penetrating peptide for drug delivery in TGFBR3 high-expressing tumors.
Published In:
Chemical biology & drug design, 102(6), 1421-1434 (2023)
Database ID:
RPEP-07562

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07562·https://rethinkpeptides.com/research/RPEP-07562

APA

Wu, Yi-Jie; Lei, Jin; Zhao, Jian; Cao, Xue-Wei; Wang, Fu-Jun. (2023). Design and characterization of a novel tumor-homing cell-penetrating peptide for drug delivery in TGFBR3 high-expressing tumors.. Chemical biology & drug design, 102(6), 1421-1434. https://doi.org/10.1111/cbdd.14333

MLA

Wu, Yi-Jie, et al. "Design and characterization of a novel tumor-homing cell-penetrating peptide for drug delivery in TGFBR3 high-expressing tumors.." Chemical biology & drug design, 2023. https://doi.org/10.1111/cbdd.14333

RethinkPeptides

RethinkPeptides Research Database. "Design and characterization of a novel tumor-homing cell-pen..." RPEP-07562. Retrieved from https://rethinkpeptides.com/research/wu-2023-design-and-characterization-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.